Neurodegenerative disease test kit INNOTEST®

for total tau proteincerebrospinal fluidenzyme immunoassay

NNOTEST PHOSPHO-TAU(181P) is a solid-phase enzyme immunoassay for the quantitative determination of phosphorylated Tau (Phospho-Tau(181P)) in human cerebrospinal fluid (CSF). The combined use of CSF-Tau and CSF-β-amyloid(1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression. The discrimination of AD from non-AD types of dementia such as dementia with Lewy Bodies may be further improved using the quantification of CSF-phospho-Tau(181). Details Features & Benefits User-friendly enzyme immunoassay, standard technology Generic and color-coded components Easily automated on microplate processor (generic components) Ready-to-use Calibrators reduce inter and intra run variation Run Validation Controls for assay run validation Limit of Detection: 13 pg/mL